623 related articles for article (PubMed ID: 36034447)
1. Gut microbiota: A new target for T2DM prevention and treatment.
Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
[TBL] [Abstract][Full Text] [Related]
2. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
Wu J; Yang K; Fan H; Wei M; Xiong Q
Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
[TBL] [Abstract][Full Text] [Related]
3. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.
Zhang L; Chu J; Hao W; Zhang J; Li H; Yang C; Yang J; Chen X; Wang H
Mediators Inflamm; 2021; 2021():5110276. PubMed ID: 34447287
[TBL] [Abstract][Full Text] [Related]
5. Fermented dietary fiber from soy sauce residue exerts antidiabetic effects through regulating the PI3K/AKT signaling pathway and gut microbiota-SCFAs-GPRs axis in type 2 diabetic mellitus mice.
Mo Z; Zhan M; Yang X; Xie P; Xiao J; Cao Y; Xiao H; Song M
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132251. PubMed ID: 38729488
[TBL] [Abstract][Full Text] [Related]
6. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
[TBL] [Abstract][Full Text] [Related]
7. Role of the gut microbiota in type 2 diabetes and related diseases.
Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
[TBL] [Abstract][Full Text] [Related]
9. Gut-targeted therapies for type 2 diabetes mellitus: A review.
Xu TC; Liu Y; Yu Z; Xu B
World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
[TBL] [Abstract][Full Text] [Related]
10. Will intestinal flora therapy become a new target in type-2 diabetes mellitus? A review based on 13 clinical trials.
Wang F; Zhao T; Wang W; Dai Q; Ma X
Nutr Hosp; 2022 Mar; 39(2):425-433. PubMed ID: 34844413
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the synthesis of short-chain fatty acids under the influence of various factors in healthy people and patients with type 2 diabetes mellitus].
Demidova TY; Teplova AS
Vopr Pitan; 2024; 93(1):33-43. PubMed ID: 38555608
[TBL] [Abstract][Full Text] [Related]
12. Uygur type 2 diabetes patient fecal microbiota transplantation disrupts blood glucose and bile acid levels by changing the ability of the intestinal flora to metabolize bile acids in C57BL/6 mice.
Wang C; Wang Y; Yang H; Tian Z; Zhu M; Sha X; Ran J; Li L
BMC Endocr Disord; 2022 Sep; 22(1):236. PubMed ID: 36151544
[TBL] [Abstract][Full Text] [Related]
13. Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites.
Chen S; Jiao Y; Han Y; Zhang J; Deng Y; Yu Z; Wang J; He S; Cai W; Xu J
Acta Diabetol; 2024 Apr; 61(4):393-411. PubMed ID: 38227209
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
Zhou Z; Sun B; Yu D; Zhu C
Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
[TBL] [Abstract][Full Text] [Related]
15. Potential type 2 diabetes mellitus drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota.
Liu H; Qin Y; Li K; Li M; Yang J; Tao H; Tang Y; Yang L; Chen S; Liu Y; Yang C; Gao W; Sun T
Br J Pharmacol; 2021 Feb; 178(4):946-963. PubMed ID: 33284460
[TBL] [Abstract][Full Text] [Related]
16. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
[TBL] [Abstract][Full Text] [Related]
17. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.
Wang M; Li L; Chen Y; Lian G; Wang J; Zhang J; Shan K; Shang L; Tian F; Jing C
Obes Surg; 2021 Jan; 31(1):327-336. PubMed ID: 32974816
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of hyperglycaemia and hyperlipidaemia by adjusting the interplay between gut microbiota and bile acid metabolism: Radix Scutellariae as a case.
Zhao L; Ma P; Peng Y; Wang M; Peng C; Zhang Y; Li X
Phytomedicine; 2021 Mar; 83():153477. PubMed ID: 33545549
[TBL] [Abstract][Full Text] [Related]
19. PuRenDan alleviates type 2 diabetes mellitus symptoms by modulating the gut microbiota and its metabolites.
Ma X; Qiu Y; Mao M; Lu B; Zhao H; Pang Z; Li S
J Ethnopharmacol; 2024 Mar; 322():117627. PubMed ID: 38147943
[TBL] [Abstract][Full Text] [Related]
20. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
